|
|
Tanzania
|
TAN 25 HM 0342
|
Dobataf EM
|
Cellulose, Microcrystalline (PH-102) 88.750 mg/tablet,Croscarmellose Sodium 28.000 mg/tablet,Emtricitabine 200 mg,Magnesium Stearate.. 2.625 mg/tablet,Opadry II white 85F18422 10.500 mg/tablet,Purified water USP-NF/Ph.Eu q.s Liter,Tenofovir Alafenamide Fumarate 25 mg
|
APL Healthcare Limited, (Unit - IV)
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 25 HM 0341
|
Ablado DT
|
Abacavir sulfate equivalent to Abacavir 60 mg/6 mL,Acesulfame potassium 12.000 mg,Crospovidone 14.000 mg,Crospovidone 14.400 mg,Dolutegravir Sodium 5 mg,Ferric Oxide 0.020 mg,Lamivudine 30 mg,Mannitol 14.540 mg,Microcrystalline cellulose 6.000 mg,Opadry II Pink 85F94172 9.500 mg,Povidone 1.500 mg,Purified Water Q.S mg,Silicified microcrystalline celluloase 107.922 mg,Silicified microcrystalline celluloase 86.380 mg,Sodium Starch Glycolate (Type A). 1.500 mg,Sodium Stearyl Fumarate 3.600 mg,Sodium Stearyl Fumarate 4.000 mg,Strawberry Cream Flavor Permaseal 11407-31 3.800 mg,Sucralose 4.800 mg
|
APL Healthcare Limited, (Unit - IV)
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 26 HB 0217
|
Dobataf 3
|
Croscarmellose Sodium 28.000 mg/6 mL,Dolutegravir Sodium 52.600 mg/6 mL,Emtricitabine 200.000 mg/6 mL,Ferric Oxide 0.020 mg/6 mL,Magnesium Stearate 2.625 mg/6 mL,Mannitol 143.380 mg/6 mL,Microcrystalline cellulose 60.000 mg/6 mL,Microcrystalline cellulose PH 102 88.750 mg/6 mL,Opadry II white 85F18422 19.500 mg/6 mL,Povidone 17.000 mg/6 mL,Purified Water. q.s mg/ml,Sodium Starch Glycolate 15.000 mg/6 mL,Sodium Starch Glycolate 6.000 mg/6 mL,Sodium Stearyl Fumarate 6.000 mg/6 mL,Tenofovir Alafenamide 28.000 mg/6 mL
|
Aurobindo Pharma Ltd
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-2249
|
ABLADO
|
Abacavir sulfate, Dolutegravir sodium and Lamivudine
|
APL HEALTHCARE LIMITED (SUBSIDIARY OF AUROBINDO PHARMA LTD)
|
Registered
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-2145
|
ABLADO DT
|
ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM AND LAMIVUDINE
|
APL Healthcare Limited
|
Registered
|
Details →
|
|
|
Ghana
|
FDA/SD.255-071208
|
ABLADO DT TABLETS
|
Abacavir Sulfate/Dolutegravir Sodium/Lamivudine
|
APL Healthcare Limited, - (Unit- IV) Plot No.16 APIIC Multi Products SEZ Menakuru Village Naidupeta Mandal Tirupati District Andhra Pradesh, India.
|
Valid
|
Details →
|
|
|
Ghana
|
FDA/SD.255-071207
|
ABLADO TABLETS
|
Abacavir Sulfate/Dolutegravir Sodium/Lamivudine
|
APL Healthcare Limited, - (Unit- IV) Plot No.16 APIIC Multi Products SEZ Menakuru Village Naidupeta Mandal Tirupati District Andhra Pradesh, India.
|
Valid
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-25-253
|
Ablado DT
|
Abacavir Sulfate USP 70.278 mg
|
APL Healthcare Limited, Unit-IV
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TZ 20 H 0115
|
Abacavir, Dolutegravir and Lamivudine
|
Abacavir Sulphate 600 mg,Dolutegravir Sodium 50 mg,Lamivudine 300 mg
|
APL Healthcare Limited, (Unit– IV)
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-2169
|
DOBATAF-3
|
Dolutegravir, Emtricitabine and Tenofovir Alafenamide
|
APL HEALTHCARE LIMITED
|
Registered
|
Details →
|
|
|
Tanzania
|
TZ 19 H 0398
|
Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate
|
Dolutegravir Sodium 50 mg,Lamivudine 300 mg,Tenofovir Disoproxil Fumarate 300 mg
|
APL Healthcare Limited, (Unit– IV)
|
Registered/Compliant
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/11918
|
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
|
-
|
APL HEALTHCARE LIMITED, UNIT-IV PLOT NO. 16, APIIC MULTI PRODUCTS SEZ, MENAKURU VILLAGE, NAIDUPETA MANDAL S.P.S.R. NELLORE DIST
|
Registered
|
Details →
|
|
|
Uganda
|
NDA/MAL/HDP/12053
|
ABACAVIR SULFATE + DOLUTEGRAVIR SODIUM + LAMIVUDINE
|
-
|
1. APL HEALTHCARE LIMITED, UNIT-IV PLOT NO. 16, APIIC MULTI PRODUCTS SEZ, MENAKURU VILLAGE, NAIDUPETA MANDAL S.P.S.R. NELLORE DIST INDIA SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT
|
Registered
|
Details →
|